Physician profile
Sheri Weinstein
NPI 1881686822
$1,376.78
in general payments reported to CMS, 2019-2025
23 companies · $61.75 in 2025
The $61.75 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $465 · 2020: $104 · 2021: $18.99 · 2022: $234 · 2023: $219 · 2024: $274 · 2025: $61.75.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $555.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $555.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $397.55 | 2019-2025 | Evenity, Otezla, Repatha |
| Abbvie INC. | $222.90 | 2020-2025 | Ubrelvy |
| Eisai INC. | $163.78 | 2023-2024 | |
| Pfizer INC. | $76.05 | 2019-2025 | |
| Merz North America, INC. | $59.88 | 2019-2021 | |
| Novo Nordisk INC | $59.69 | 2022-2024 | Ozempic, Rybelsus |
| Glaxosmithkline, LLC. | $48.71 | 2019-2024 | Trelegy Ellipta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $44.91 | 2019 | |
| Exact Sciences Corporation | $33.36 | 2024 | Cologuard Collection Kit |
| Millicent US INC | $31.71 | 2019 | |
| Convatec INC. | $28.54 | 2023 | |
| Novartis Pharmaceuticals Corporation | $25.73 | 2019-2020 | |
| Horizon Therapeutics Plc | $20.48 | 2019 | |
| Alfasigma USA, INC. | $18.91 | 2020 | |
| Halozyme INC | $18.77 | 2023 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avion Pharmaceuticals | $18.65 | 2024 | NP Thyroid 60 |
| Aclaris Therapeutics, INC. | $17.54 | 2019 | |
| Nestle Healthcare Nutrition INC. | $17.53 | 2023 | |
| Ge Healthcare | $16.87 | 2023 | |
| Astellas Pharma US INC | $15.71 | 2023 | Myrbetriq |
| Therapeuticsmd, INC. | $15.68 | 2019 | |
| Acella Pharmaceuticals, LLC | $12.22 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $11.61 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sheri Weinstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.